Sarcoma  >>  Campath (alemtuzumab)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Campath (alemtuzumab) / Sanofi
NCT01625351: A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas

Completed
1
23
US
alemtuzumab, CAMPATH-1H, Campath(R), fludarabine, Fludara(R), sirolimus, Rapamycin, Rapamune(R), Busulfan, Busulfex(R), Myleran(R), melphalan, L-phenylalanine mustard, phenylalanine mustard, L-PAM, L-sarcolysin, stem cells, HSCT, Stem cell transplantation, CliniMACS, Cell Selection System
St. Jude Children's Research Hospital, CURE Childhood Cancer, Inc.
Ewing Sarcoma, Gastrointestinal Tumor, Germ Cell Tumor, Hepatic Tumor, Lymphoma, Wilms Tumor, Rhabdoid Tumor, Clear Cell Carcinoma, Renal Cell Carcinoma, Melanoma, Neuroblastoma, Rhabdomyosarcoma, Non-rhabdomyosarcoma
02/20
02/20

Download Options